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CHAPTER 1 
INTRODUCTION 
1.1 General 
 Type 2 diabetes (non-insulin-dependent diabetes mellitus) is a chronic 
metabolic disease that results from defects in insulin secretion and insulin receptor 
kinase.  Investigation of novel small active molecule that can potentiate insulin 
action or having a similar action as insulin is important in the treatment of diabetes.  
World ethnobotanical information on medicinal plants reports almost 800 plants used 
in the treatment of diabetes mellitus.  However, only a small number of them have 
been studied thoroughly (Alarcon-Aguilar et al., 1998). 
Cell line provides a continuous source of large numbers of cells necessary for 
study of proliferation and differentiation.  The 3T3-L1 cell line is selected for this 
study because it plays an important role in lipid storage and glucose homeostasis. 
3T3-L1 adipocytes have been used extensively to study the regulation of such as 
glucose transporters, cell proliferation and insulin signaling.  During differentiation, 
3T3-L1 cells experience a 20-fold increase in the number of insulin receptors and 
acquire the ability to utilize glucose in response to insulin (Frost and Lane, 1985). 
The most frequently employed adipocytes cell lines are 3T3-F442A and 3T3-L1. 
They were clonally isolated from Swiss 3T3 cells derived from disaggregated 17-
to19-day mouse embryos (Green and Kehinde, 1975 and 1976). 
21.2 Plants in Type 2 Diabetes Treatment 
 The plant extracts and its product play an important role in treating many 
symptoms.  Pioneering studies on the active constituents of Podophyllum peltatum
followed by the discovery and development of the antileukemic agents, vinblastine 
and vincristine from Catharantus roseus provided convincing evidence that plants 
could be sources of novel and potential chemotherapeutic agents (Baker et al., 1995). 
 Imparl-Radosevich et al.  (1998), Jarvill-Taylor et al.  (2001), Anderson et al.
(2004) and Pszczola (2001) have introduced method to evaluate plants compound for 
antihyperglycemia activity.  The plant used is cinnamon and suggested to contain a 
novel phenolic polymer.  The compound stimulated phosphorylation insulin receptor 
and enhance glucose uptake in 3T3-L1 adipocytes.  Khan et al.  (2003) reported the 
effect of Cinnamomum cassia on the diabetes patients.  The results of their study 
demonstrate that intake of 1, 3, or 6 g of cinnamon per-day reduces serum glucose, 
triglyceride, LDL cholesterol, and total cholesterol in people with type 2 diabetes. 
They suggested that the inclusion of cinnamon in the diet of people with type 2 
diabetes reduces the risk factors associated with diabetes and cardiovascular diseases. 
There are several bioactive plant extracts that have been studied for 
antidiabetic agent.  A bioactive compound from Chinese plant Lithospermum 
erythrorhizon stimulates glucose uptake in 3T3-L1 adipocytes (Kamei  et al., 2002).  
An extract from Lagerstroemia speciosa has insulin like glucose uptake stimulatory 
effect (Liu et al., 2001). In addition, an antidiabetic fungal metabolite from culture 
broth of Pseudomassaria sp. was discovered as an insulin agonist and showed to be 
highly effective in animal models diabetes (Qureshi et al., 2000). 
1.2.1 Insulin-mimetic Compounds  
The cellular response to insulin is mediated through the insulin receptor (IR), 
which is a tetrameric protein consisting of two identical extracellular ?-subunits that 
bind insulin as well as two identical transmembrane ?-subunits that have intracellular 
3tyrosine kinase activity (White, 1997; White et al.,  1985 and 1994).  Insulin 
resistance, an important feature of type 2 diabetes, is manifested as attenuated insulin 
receptor (IR) signaling in response to insulin binding.  A drug that promotes the 
initiation of IR signaling by enhancing IR autophosphorylation should, therefore, be 
useful for treating type 2 diabetes. 
In order to discover a non peptide, small active compound that exhibited 
insulin-mimetic activity, Salituro et al.  (2001) screened over 50,000 samples of 
natural extracts for their ability to mimic insulin activity.  They recently discovered a 
small non-peptidyl molecule (L-783,281) from a fungal (Pseudomassaria) extract 
(Zhang et al., 1999; Ding et al., 2002; Qureshi et al., 2000).  Purification of the 
active compound revealed that demethylasterriquinone B1 (known as L-783,281) 
structurally belong to quinone-like structure of natural product.  L-783,281 seems to 
bind directly to the intracellular??-subunit of the insulin receptor containing the 
insulin receptor tyrosine kinase activity.  Binding leads to a conformational change 
resulting in activation of the kinase and induction of the insulin signaling cascade 
downstream of the receptor at micromolar concentrations.  L-783,281 leads to 
phosphorylation of a number of proteins of the insulin signaling pathway including 
the ?-subunit of the insulin receptor, the insulin receptor substrate-1 and the Akt-
kinase (or protein kinase B).  In addition, it stimulates phosphoinositol 3-kinase.  L-
783,281 was also shown to increase glucose uptake in primary adipocytes and in 
soleus muscle. 
Manchem et al. (2001) found a chemical called as TLK16,998.  This 
compound activated the tyrosine kinase domain of the IR ?-subunit at concentrations 
of 1 µmol/l or less but had no effect on insulin binding to the IR ?-subunit even at 
much higher concentrations.  TLK16,998 alone had no effect on IR signaling in 
mouse 3T3-L1 adipocytes but, at concentrations as low as 3.2 µmol/l, enhanced the
effects of insulin on the phosphorylation of the IR ?-subunit and IR substrate-1, and 
on the amount of phosphatidylinositol 3-kinase that coimmunoprecipitated with IR 
substrate-1.
41.3 Diabetes Mellitus 
According to International Diabetes Federation, currently more than 194 
million people with diabetes worldwide and the epidemiological estimates that by 
2025 there will be 333 million diabetes sufferers. It will be almost twice as many 
sufferers as today, and has become a serious public health problem, particularly in 
developed countries.  This will be predominantly individuals with type 2 diabetes 
(Vessby, 2000; Seidell, 2000; Kim et al., 2001; Barrett, 2004).   
Type 2 diabetes mellitus is an increasingly common disorder of carbohydrate 
and lipid metabolism (Nadler and Attie, 2001).  Two important characteristics of this 
disease are insulin resistance, the failure of peripheral tissues; including liver, 
muscle, and adipose tissue, to respond to physiologic doses of insulin, and failure of 
pancreatic ?-cells to properly secrete insulin in response to elevated blood glucose 
levels.  Obesity is a significant risk factor for the development of type 2 diabetes 
mellitus.  An extremely lean and lipoatrophic models have revealed a similar 
predisposition to developing diabetes.  Although it may seem paradoxical that both 
increased adiposity and severely reduced fat mass cause diabetes, a common 
pathophysiologic process in fat may be responsible for the predisposition to develop 
hyperglycemia in both conditions (Kim et al., 2001; Nadler and Attie, 2001). 
Broadhurst (1997) proposed the major causative factors for non-insulin 
dependent-diabetes mellitus (NIDDM) involving obesity and overfatness; 
carbohydrate and fat over nutrition; lack of polyunsaturated fatty acids (PUFA) in 
plasma membranes and unbalanced triglyceride intake; chromium deficiency; and 
lack of soluble fiber and relevant beneficial phytochemicals. 
NIDDM is a complex disease that is currently thought to be influenced by 
more than a single gene or environmental factor.  Although the relative contribution 
of genetic and environmental factors to the development of NIDDM differs among 
individuals, patients generally have two common metabolic abnormalities: insulin 
resistance and defects in glucose-stimulated insulin secretion, which lead to disease 
state (Fig.1.1). 
5Figure 1.1 Schematic diagram of progressive pathogenesis of NIDDM (Jun et al.,
1999). 
Figure 1.2 shows that glucose affects insulin release by acting in multiple 
ionic and metabolic mechanisms.  ? cells are sensitive to the concentration of 
glucose.  If ? cells are exposed to elevated glucose levels for more than 15 min, they 
become primed so that their response to glucose becomes greater than their initial 
response.  Glucose inhibits ATP-sensitive K+ channels (possibly by its stimulation of 
ATP production), which causes membrane depolarization.  Depolarization activates 
Ca2+ channels resulting in Ca2+ entry and an increase in cytosolic Ca2+.  Extracellular 
Ca2+ production and energy production are required for stimulation of insulin 
secretion.  During glucose stimulation of healthy ? cells, normal insulin secretion 
takes place.  However, in defective ? cells, impaired insulin secretion may cause 
delayed insulin secretion.  The insulin receptor substrate-1 (IRS-1) molecule is 
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thought to transmit the intracellular signal from the insulin receptor.  The binding of 
insulin to the insulin receptor leads to activation of insulin receptor kinase through 
autophosphorylation of the insulin receptor (?-subunit).  Insulin receptor kinase is 
essential for insulin action.  In type II diabetes, the insulin receptor kinase activity 
appears to be lower in target tissue due to a decreased number of insulin receptors 
and a reduction in intrinsic insulin receptor kinase activity per-receptor. 
Figure 1.2 Schematic diagram of metabolic functions in ? cells, insulin secretion 
in ? cells, and insulin action in target tissues (Jun et al., 1999). 
1.4       Culture Model for Hypoglycemic Activity 
Mammalian cell cultures are continuously drawing major research effort.  A 
great deal of progress has recently been made in cellular physiology, especially in 
factors adversely affecting cell growth and viability.  There are many advantageous 
in using cell culture for assay.  They provide a continuous supply of homogenous 
cellular material for biochemical experiments as well as for practical use in medical 
and public health work.  The cells in vitro can be manipulated advantageously in 
7many ways, unlike with cells in vivo (Jacoby et al., 1979).  The screening of new 
compounds including plant extracts for antidiabetic effects have been investigated by 
the researchers.  The recommended method for the study antidiabetic effect of plant 
extracts is by in vitro or in vivo (Verspohl, 2002).   
1.5 Objective of the Study 
The objective of the study was to evaluate insulin mimetic activity of 
Cinnamomum zeylanicum on 3T3-L1 adipocyte.  To achieve the objective, two major 
research scopes were carried out: 
1. Isolation and characterization of active compound from Cinnamomum 
zeylanicum.
2. Cell-based in vitro assay for the insulin mimetic activity of the active 
compound on 3T3-L1 adipocytes.   
